(Q41774137)
Statements
1 reference
A phase II study of the administration of recombinant interleukin 2 (rIL-2) plus lymphokine activated killer (LAK) cells in stage IV melanoma patients (English)
1 reference
Cascinelli N
1 reference
Belli F
1 reference
Marchini S
1 reference
Marolda R
1 reference
Prada A
1 reference
Sciorelli G
1 reference
Villani F
1 reference
Gambacorti-Passerini C
1 reference
Galazka A
1 reference
Parmiani G
1 reference
1 June 1989
1 reference
1 reference
75
1 reference
3
1 reference
233-244
1 reference
Identifiers
1 reference